<DOC>
	<DOCNO>NCT01120132</DOCNO>
	<brief_summary>The purpose study determine efficacy safety administration cyclosporine prednisolone acetate compare placebo treatment allergic conjunctivitis .</brief_summary>
	<brief_title>Study Evaluating Efficacy Administration Cyclosporine ( Low Dose High Dose ) Prednisolone Acetate Compared Its Components Vehicle Patients With Allergic Conjunctivitis</brief_title>
	<detailed_description />
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis , Allergic</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<criteria>history ocular allergy positive skin test reaction perennial allergen within past 24 month history chronic eye irritation visual acuity score â‰¥ 0.60 ( EDTS ) negative urine pregnancy test female patient , use adequate birth control throughout study period . active ocular infection ; preauricular lymphadenopathy ocular condition could affect study ; glaucoma abnormal intraocular pressure ; ocular surgery within past 3 month ; history asthma , pregnancy nursing contraindication know allergy study drug ( )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
</DOC>